Ignite Creation Date:
2024-05-06 @ 2:56 AM
Last Modification Date:
2024-10-26 @ 11:26 AM
Study NCT ID:
NCT02163694
Status:
COMPLETED
Last Update Posted:
2024-02-23
First Post:
2014-05-19
Brief Title:
A Phase 3 Randomized Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib ABT-888 in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer
Sponsor:
AbbVie
Organization:
AbbVie
Organization Data
Organization:
AbbVie
Class:
INDUSTRY
Study ID:
M12-914
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AbbVie
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None